Drugs / Interferon gamma-primed mesenchymal stromal cells (MSCs)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05035862 | Mar → Dec 2022 | asthma | Emory University | Terminated | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Interferon gamma-primed mesenchymal stromal cells (MSCs) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05035862 ↗ |
| Known as | γMSCs | “interferon gamma-primed MSCs or γMSCs” NCT05035862 ↗ |
| Route | Intravenous | “single intravenous infusion of γMSCs” NCT05035862 ↗ |